ClearPoint Neuro, Inc. (CLPT)
NASDAQ$13.6
Market Cap
$375.8M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
521 of 924
Rank in Industry
65 of 118
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
CLPT Insider Trading Activity
CLPT Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
No records found
About ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration …
Insider Activity of ClearPoint Neuro, Inc.
Over the last 12 months, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $0 worth of ClearPoint Neuro, Inc. stock.
On average, over the past 5 years, insiders at ClearPoint Neuro, Inc. have bought $0 and sold $554,758 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $31,250 was made by BURNETT JOSEPH MICHAEL (President and CEO) on 2018‑09‑25.
List of Insider Buy and Sell Transactions, ClearPoint Neuro, Inc.
| 2022-08-15 | Sale | BURNETT JOSEPH MICHAEL | CEO and President | 18,867 0.0889% | $16.07 | $303,193 | -43.20% | |
| 2021-11-11 | Sale | BURNETT JOSEPH MICHAEL | CEO and President | 10,000 0.0495% | $16.88 | $168,800 | -36.25% | |
| 2021-09-21 | Sale | BURNETT JOSEPH MICHAEL | CEO and President | 9,637 0.0508% | $17.98 | $173,273 | -37.50% | |
| 2021-06-21 | Sale | BURNETT JOSEPH MICHAEL | CEO and President | 25,000 0.1361% | $18.57 | $464,250 | -37.48% | |
| 2018-09-25 | BURNETT JOSEPH MICHAEL | President and CEO | 25,000 0.0092% | $1.25 | $31,250 | +74.16% | ||
| 2018-08-24 | BURNETT JOSEPH MICHAEL | President and CEO | 7,500 0.0035% | $1.58 | $11,850 | +87.01% | ||
| 2018-08-22 | BURNETT JOSEPH MICHAEL | President and CEO | 4,637 0.0021% | $1.55 | $7,187 | +78.13% | ||
| 2018-05-21 | BURNETT JOSEPH MICHAEL | President and CEO | 7,500 0.0052% | $2.39 | $17,903 | -12.50% | ||
| 2017-05-26 | Grillo Francis P | CHIEF EXECUTIVE OFFICER | 12,500 0.0073% | $2.00 | $25,000 | -14.06% | ||
| 2017-05-26 | Jenkins Kimble L. | director | 7,500 0.0044% | $2.00 | $15,000 | -14.06% | ||
| 2016-09-02 | Grillo Francis P | CHIEF EXECUTIVE OFFICER | 20,000 0.0293% | $5.00 | $100,000 | -39.86% | ||
| 2016-09-02 | Rooke Andrew K. | director | 10,000 0.0147% | $5.00 | $50,000 | -39.86% | ||
| 2015-12-18 | KOOB CHARLES E | director | 154,035 0.0147% | $0.32 | $50,000 | -42.50% | ||
| 2015-12-18 | Rooke Andrew K. | director | 154,035 0.0147% | $0.32 | $50,000 | -42.50% | ||
| 2015-12-18 | Grillo Francis P | CHIEF EXECUTIVE OFFICER/PRES | 308,071 0.0293% | $0.32 | $100,000 | -42.50% | ||
| 2015-12-18 | Richards Timothy T. | director | 77,017 0.0073% | $0.32 | $25,000 | -42.50% | ||
| 2014-12-24 | Sainz Maria | director | 23,310 0.0044% | $0.64 | $15,000 | -8.79% | ||
| 2014-09-12 | SPENCER JOHN N JR | director | 16,000 0.0055% | $1.18 | $18,880 | -11.61% | ||
| 2014-08-13 | SPENCER JOHN N JR | director | 3,500 0.001% | $1.00 | $3,500 | 0.00% | ||
| 2014-06-13 | Rooke Andrew K. | 30,000 0.0064% | $0.73 | $21,900 | +36.99% |
Total: 58
Insider Historical Profitability
<0.0001%
| KOOB CHARLES E | director | 736931 2.6669% | $10.02M | 1 | 0 | |
| PIETRANGELO MICHAEL | director | 451296 1.6332% | $6.14M | 7 | 0 | +2.54% |
| Malernee James K. Jr. | director | 290659 1.0519% | $3.95M | 2 | 0 | <0.0001% |
| BURNETT JOSEPH MICHAEL | CEO and President | 262095 0.9485% | $3.56M | 4 | 4 | +56.7% |
| Richards Timothy T. | director | 110005 0.3981% | $1.5M | 1 | 0 |
Historical Insider Profitability vs. Competitors
$3,117,276 | 86 | 20.26% | $65.16M | |
ClearPoint Neuro, Inc. (CLPT) | $1,105,104 | 34 | -11.40% | $375.8M |
$326,720 | 30 | -21.23% | $12.21M | |
$2,195,447 | 29 | -33.21% | $16.92M | |
$193,888 | 27 | -6.43% | $1.04M |
CLPT Institutional Investors: Active Positions
| Increased Positions | 46 | +54.12% | 2M | +25.47% |
| Decreased Positions | 30 | -35.29% | 972,462 | -14.23% |
| New Positions | 22 | New | 734,003 | New |
| Sold Out Positions | 12 | Sold Out | 247,731 | Sold Out |
| Total Postitions | 101 | +18.82% | 8M | +11.25% |
CLPT Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Vanguard Group Inc | $15,979.00 | 4.46% | 1.25M | +5,400 | +0.43% | 2024-12-31 |
| Susquehanna International Group, Llp | $6,517.00 | 1.82% | 509,164 | +358,189 | +237.25% | 2024-12-31 |
| Essex Investment Management Co Llc | $5,233.00 | 1.46% | 408,822 | -55,031 | -11.86% | 2024-12-31 |
| Blackrock, Inc. | $5,034.00 | 1.41% | 393,263 | +21,662 | +5.83% | 2024-12-31 |
| Brown Advisory Inc | $4,267.00 | 1.19% | 333,395 | 0 | 0% | 2024-12-31 |
| Cm Management, Llc | $3,712.00 | 1.04% | 290,000 | -10,000 | -3.33% | 2024-12-31 |
| Millennium Management Llc | $3,701.00 | 1.03% | 289,150 | +13,866 | +5.04% | 2024-12-31 |
| D. E. Shaw & Co., Inc. | $3,692.00 | 1.03% | 288,409 | +62,889 | +27.89% | 2024-12-31 |
| Geode Capital Management, Llc | $3,634.00 | 1.01% | 283,901 | -3,393 | -1.18% | 2024-12-31 |
| Invesco Ltd. | $3,174.00 | 0.89% | 247,977 | +247,977 | New | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.